Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tasquinimod-ketoconazole pharmacokinetic interaction study in healthy volunteers
NL-OMON35292Phase 1Active, not recruiting
- Sponsor
- PRA Health Sciences
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of tasquinimod and ketoconazole in prostate cancer (PCa), sponsored by PRA Health Sciences. Primary endpoints: Maximum plasma concentration (Cmax) of tasquinimod, Area under the concentration-time curve from time 0 to time t (AUC0-t) of tasquinimod and 7 more. Started Nov 2011; status: active, not recruiting.
02
Drugs
tasquinimodketoconazole
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NL-OMON35292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35292.